Author:
Bach Paxton,Wood Evan,Dong Huiru,Guillemi Silvia,Kerr Thomas,Montaner Julio,Milloy M-J
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Aceijas C, Stimson GV, Hickman M, Rhodes T, United Nations Reference Group on HIVAP, Care among IDUiD, Transitional C. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 2004;18(17):2295–303.
2. Control CfD: Estimated HIV incidence in the United States, 2007–2010. HIV Surveillance Supplemental Report. In., vol. 17(4); 2012
3. Andersen R, Bozzette S, Shapiro M, St Clair P, Morton S, Crystal S, et al. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study. Health Serv Res. 2000;35(2):389–416.
4. Celentano DD, Galai N, Sethi AK, Shah NG, Strathdee SA, Vlahov D, et al. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS. 2001;15(13):1707–15.
5. Lloyd-Smith E, Brodkin E, Wood E, Kerr T, Tyndall MW, Montaner JS, et al. Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia. AIDS. 2006;20(3):445–50.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献